APA (7th ed.) Citation

Houghton, L. A., Gao, S., Gilbert, S. A., Coffin, B., Simren, M., & Gale, J. D. (2025). Clinical Trial: Study to Investigate the Efficacy and Safety of the Alpha‐2‐Delta Ligand PD‐217,014 in Patients With Irritable Bowel Syndrome. Alimentary Pharmacology & Therapeutics, 61(5), 803. https://doi.org/10.1111/apt.18487

Chicago Style (17th ed.) Citation

Houghton, Lesley A., Simiao Gao, Steven A. Gilbert, Benoit Coffin, Magnus Simren, and Jeremy D. Gale. "Clinical Trial: Study to Investigate the Efficacy and Safety of the Alpha‐2‐Delta Ligand PD‐217,014 in Patients With Irritable Bowel Syndrome." Alimentary Pharmacology & Therapeutics 61, no. 5 (2025): 803. https://doi.org/10.1111/apt.18487.

MLA (9th ed.) Citation

Houghton, Lesley A., et al. "Clinical Trial: Study to Investigate the Efficacy and Safety of the Alpha‐2‐Delta Ligand PD‐217,014 in Patients With Irritable Bowel Syndrome." Alimentary Pharmacology & Therapeutics, vol. 61, no. 5, 2025, p. 803, https://doi.org/10.1111/apt.18487.